Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Inhibitory Aromatase Effects of Flavonoids from Ginkgo Biloba Extracts on Estrogen Biosynthesis.

Park YJ, Choo WH, Kim HR, Chung KH, Oh SM.

Asian Pac J Cancer Prev. 2015;16(15):6317-25.

2.

Association of a (TTTA)n microsatellite and a TCT del/ins polymorphisms in the aromatase gene (CYP19) with hip fracture risk in Mexican postmenopausal women.

Casas-Avila L, Valdés-Flores M, Miranda-Duarte A, Ponce de León-Suárez V, Castro-Hernández C, Rubio-Lightbourn J, Hidalgo-Bravo A.

Gynecol Endocrinol. 2015;31(12):987-91. doi: 10.3109/09513590.2015.1092511. Epub 2015 Oct 1.

PMID:
26426292
3.

Sex- and Obesity-specific Association of Aromatase (CYP19A1) Gene Variant with Apolipoprotein B and Hypertension.

Coban N, Onat A, Guclu-Geyik F, Can G, Erginel-Unaltuna N.

Arch Med Res. 2015 Oct;46(7):564-71. doi: 10.1016/j.arcmed.2015.09.004. Epub 2015 Sep 26.

PMID:
26415088
4.

C-Jun NH2-Terminal Kinase and p38 Inhibition Suppresses Prostaglandin E2-Stimulated Aromatase and Estrogen Receptor Levels in Human Endometriosis.

Zeng C, Xu JN, Zhou Y, Yang HX, Zhou YF, Xue Q.

J Clin Endocrinol Metab. 2015 Nov;100(11):E1404-14. doi: 10.1210/jc.2015-2031. Epub 2015 Sep 22.

PMID:
26394174
5.

Influence of Genetic Ancestry on INDEL Markers of NFKβ1, CASP8, PAR1, IL4 and CYP19A1 Genes in Leprosy Patients.

Pinto P, Salgado C, Santos NP, Santos S, Ribeiro-dos-Santos Â.

PLoS Negl Trop Dis. 2015 Sep 14;9(9):e0004050. doi: 10.1371/journal.pntd.0004050. eCollection 2015.

6.

Evolutionary comparisons predict that dimerization of human cytochrome P450 aromatase increases its enzymatic activity and efficiency.

Martin LL, Holien JK, Mizrachi D, Corbin CJ, Conley AJ, Parker MW, Rodgers RJ.

J Steroid Biochem Mol Biol. 2015 Nov;154:294-301. doi: 10.1016/j.jsbmb.2015.09.006. Epub 2015 Sep 7.

PMID:
26361012
7.

Polymorphisms in CYP19A1, HSD17B1 and HSD17B2 genes and serum sex hormone level among postmenopausal Japanese women.

Hosono S, Ito H, Oze I, Higaki Y, Morita E, Takashima N, Suzuki S, Shimatani K, Mikami H, Ohnaka K, Ozaki E, Katsuura-Kamano S, Kubo M, Nagata C, Naito M, Hamajima N, Tanaka H; Japan Multi-Institutional Collaborative Cohort (J-MICC) Study Group.

Maturitas. 2015 Dec;82(4):394-401. doi: 10.1016/j.maturitas.2015.08.003. Epub 2015 Aug 13.

PMID:
26323233
8.

Vaginal Gene Expression During Treatment With Aromatase Inhibitors.

Kallak TK, Baumgart J, Nilsson K, Åkerud H, Poromaa IS, Stavreus-Evers A.

Clin Breast Cancer. 2015 Dec;15(6):527-535.e2. doi: 10.1016/j.clbc.2015.06.012. Epub 2015 Jul 6.

PMID:
26283501
9.

An Intron 9 CYP19 Gene Variant (IVS9+5G>A), Present in an Aromatase-Deficient Girl, Affects Normal Splicing and Is Also Present in Normal Human Steroidogenic Tissues.

Saraco N, Nesi-Franca S, Sainz R, Marino R, Marques-Pereira R, La Pastina J, Perez Garrido N, Sandrini R, Rivarola MA, de Lacerda L, Belgorosky A.

Horm Res Paediatr. 2015;84(4):275-82. doi: 10.1159/000437142. Epub 2015 Aug 5.

PMID:
26279340
10.

RRM1, TUBB3, TOP2A, CYP19A1, CYP2D6: Difference between mRNA and protein expression in predicting prognosis of breast cancer patients.

Xu YC, Zhang FC, Li JJ, Dai JQ, Liu Q, Tang L, Ma Y, Xu Q, Lin XL, Fan HB, Wang HX.

Oncol Rep. 2015 Oct;34(4):1883-94. doi: 10.3892/or.2015.4183. Epub 2015 Aug 7.

PMID:
26252353
11.

Leptin, its receptor and aromatase expression in deep infiltrating endometriosis.

Gonçalves HF, Zendron C, Cavalcante FS, Aiceles V, Oliveira MA, Manaia JH, Babinski MA, Ramos CF.

J Ovarian Res. 2015 Aug 5;8:53. doi: 10.1186/s13048-015-0180-0.

12.

Association of Single Nucleotide Polymorphisms in the CYP19A1 Gene with Female Pattern Hair Loss in a Chinese Population.

Rui W, Sheng Y, Hu R, Miao Y, Han Y, Guo X, Qi S, Xu F, Xu J, Yang Q.

Dermatology. 2015;231(3):239-44. doi: 10.1159/000433597. Epub 2015 Jul 24.

13.

Aromatase overexpression in dysfunctional adipose tissue links obesity to postmenopausal breast cancer.

Wang X, Simpson ER, Brown KA.

J Steroid Biochem Mol Biol. 2015 Sep;153:35-44. doi: 10.1016/j.jsbmb.2015.07.008. Epub 2015 Jul 21. Review.

PMID:
26209254
14.

Follicular hyperandrogenism downregulates aromatase in luteinized granulosa cells in polycystic ovary syndrome women.

Yang F, Ruan YC, Yang YJ, Wang K, Liang SS, Han YB, Teng XM, Yang JZ.

Reproduction. 2015 Oct;150(4):289-96. doi: 10.1530/REP-15-0044. Epub 2015 Jul 21.

PMID:
26199450
15.

S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.

Shao X, Cai J, Zheng Y, Wang J, Feng J, Huang Y, Shi L, Chen Z, Guo Y, Wang X.

Int J Clin Exp Pathol. 2015 May 1;8(5):5309-17. eCollection 2015.

16.
17.

Compensatory Increase in Ovarian Aromatase in Older Regularly Cycling Women.

Shaw ND, Srouji SS, Welt CK, Cox KH, Fox JH, Adams JA, Sluss PM, Hall JE.

J Clin Endocrinol Metab. 2015 Sep;100(9):3539-47. doi: 10.1210/JC.2015-2191. Epub 2015 Jun 30.

18.

A translational bioinformatic approach in identifying and validating an interaction between Vitamin A and CYP19A1.

Philips S, Zhou J, Li Z, Skaar TC, Li L.

BMC Genomics. 2015;16 Suppl 7:S17. doi: 10.1186/1471-2164-16-S7-S17. Epub 2015 Jun 11.

19.

Analysis of the complex formation, interaction and electron transfer pathway between the "open" conformation of NADPH-cytochrome P450 reductase and aromatase.

Dai Y, Zhen J, Zhang X, Zhong Y, Liu S, Sun Z, Guo Y, Wu Q.

Steroids. 2015 Sep;101:116-24. doi: 10.1016/j.steroids.2015.06.006. Epub 2015 Jun 15.

PMID:
26087061
20.

Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis.

Artigalás O, Vanni T, Hutz MH, Ashton-Prolla P, Schwartz IV.

BMC Med. 2015 Jun 11;13:139. doi: 10.1186/s12916-015-0373-9.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk